Édith Guilbert
YOU?
Author Swipe
View article: Extended duration of use of long-acting reversible contraceptives
Extended duration of use of long-acting reversible contraceptives Open
Prolonged use of LARCs is safe and much more effective than short-acting contraceptive methods. Prolonged use of LARCs might be beneficial for individuals requiring contraception especially those with disrupted access to social and health …
View article: Development and pilot testing of the 2019 Canadian Abortion Provider Survey
Development and pilot testing of the 2019 Canadian Abortion Provider Survey Open
Background Substantial changes in abortion care regulations, available medications and national clinical practice guidelines have occurred since a 2012 national Canadian Abortion Provider Survey (CAPS). We developed and piloted the CAPS 20…
View article: First-trimester surgical abortion practice in Canada in 2012
First-trimester surgical abortion practice in Canada in 2012 Open
First-trimester surgical abortion providers are mostly family physicians and most are female. Practices across Canada were mostly uniform and followed evidence-based guidelines. Uptake of the most recent Canadian practice guidelines may he…
View article: Telemedicine for First-Trimester Medical Abortion in Canada: Results of a 2019 Survey
Telemedicine for First-Trimester Medical Abortion in Canada: Results of a 2019 Survey Open
Introduction: Telemedicine has the potential to improve abortion access disparities in Canada. We aimed to explore the provision of telemedicine for first-trimester medical abortion and related barriers in 2019. Methods: We conducted a nat…
View article: Abortion services and providers in Canada in 2019: results of a national survey
Abortion services and providers in Canada in 2019: results of a national survey Open
The increased availability of medical abortion facilitates abortion access, especially in primary care and rural settings, and where surgical abortion is not available. Rejuvenation of the workforce is a critical contributor to equitable a…
View article: A Virtual Community of Practice to Support Physician Uptake of a Novel Abortion Practice: Mixed Methods Case Study
A Virtual Community of Practice to Support Physician Uptake of a Novel Abortion Practice: Mixed Methods Case Study Open
Background Virtual communities of practice (VCoPs) have been used to support innovation and quality in clinical care. The drug mifepristone was introduced in Canada in 2017 for medical abortion. We created a VCoP to support implementation …
View article: The 2019 canadian abortion provider survey
The 2019 canadian abortion provider survey Open
CONTEXT: Recently, updated Canadian surgical and medical abortion practice guidelines were released, mifepristone was approved by Health Canada for first trimester medical abortion (FTMA) as a regular prescription, and nurse practitioners …
View article: Development of a fraud detection plan in a survey of canadian abortion providers.
Development of a fraud detection plan in a survey of canadian abortion providers. Open
CONTEXT: Prevention and detection of fraudulent online survey responses is challenging for researchers. OBJECTIVE: Describe the development and implementation of a fraudulent response identification plan in the online Canadian Abortion Pro…
View article: A Virtual Community of Practice to Support Physician Uptake of a Novel Abortion Practice: Mixed Methods Case Study (Preprint)
A Virtual Community of Practice to Support Physician Uptake of a Novel Abortion Practice: Mixed Methods Case Study (Preprint) Open
BACKGROUND Virtual communities of practice (VCoPs) have been used to support innovation and quality in clinical care. The drug mifepristone was introduced in Canada in 2017 for medical abortion. We created a VCoP to support implementation…
View article: POSTER ABSTRACTS
POSTER ABSTRACTS Open
Objectives: Mifepristone became available for first trimester medical abortion (FTMA) in Canada in 2017. Additionally, regulations allow pharmacies to dispense mifepristone directly to patients, facilitating telemedicine. Our objective was…
View article: POSTER ABSTRACTS
POSTER ABSTRACTS Open
Objectives: Canada was positioned to transition to telemedicine abortion care during the COVID-19 pandemic because REMs-like mifepristone restrictions were removed previously. We sought to characterize the impact of the pandemic response o…
View article: Pharmacist dispensing of the abortion pill in Canada: Diffusion of Innovation meets integrated knowledge translation
Pharmacist dispensing of the abortion pill in Canada: Diffusion of Innovation meets integrated knowledge translation Open
Background Since Canadian drug regulatory approval of mifepristone for medical abortion in 2015 and its market availability in January 2017, the role of pharmacists in abortion provision has changed rapidly. We sought to identify the facto…
View article: The perspective of Canadian health care professionals on abortion service during the COVID-19 pandemic
The perspective of Canadian health care professionals on abortion service during the COVID-19 pandemic Open
Background The COVID-19 pandemic and pandemic response created novel challenges for abortion services. Canada was uniquely positioned to transition to telemedicine because internationally common restrictions on abortion medication were rem…
View article: Perspectives Among Canadian Physicians on Factors Influencing Implementation of Mifepristone Medical Abortion: A National Qualitative Study
Perspectives Among Canadian Physicians on Factors Influencing Implementation of Mifepristone Medical Abortion: A National Qualitative Study Open
Health Canada's removal of mifepristone restrictions facilitated the implementation of abortion care in the primary care setting. Our results are unique because Canada is the first country to facilitate provision of medical abortion in pri…
View article: Slow implementation of mifepristone medical termination of pregnancy in Quebec, Canada: a qualitative investigation
Slow implementation of mifepristone medical termination of pregnancy in Quebec, Canada: a qualitative investigation Open
Objectives: Mifepristone for first-trimester medical termination of pregnancy (MTOP) became available in Quebec in 2018, one year after the rest of Canada. Using the theory of the Diffusion of Innovation (DOI) and the transtheoretical mode…
View article: Could implementation of mifepristone address Canada’s urban–rural abortion access disparity: a mixed-methods implementation study protocol
Could implementation of mifepristone address Canada’s urban–rural abortion access disparity: a mixed-methods implementation study protocol Open
Introduction In January 2017, mifepristone-induced medical abortion was made available in Canada. In this study, we will seek to (1) understand facilitators and barriers to the implementation of mifepristone across Canada, (2) assess the i…
View article: First trimester medication abortion practice in the United States and Canada
First trimester medication abortion practice in the United States and Canada Open
We conducted a cross-sectional survey of abortion facilities from professional networks in the United States (US, n = 703) and Canada (n = 94) to estimate the prevalence of medication abortion practices in these settings and to look at reg…
View article: Abortion health services in Canada: Results of a 2012 national survey.
Abortion health services in Canada: Results of a 2012 national survey. Open
Access to abortion services varies by region across Canada. Services are not equitably distributed in relation to the regions where reproductive-age women reside. British Columbia and Quebec have demonstrated effective strategies to addres…
View article: First-trimester medical abortion practices in Canada: National survey.
First-trimester medical abortion practices in Canada: National survey. Open
In Canada, MA provision using methotrexate and misoprostol is consistent with best-practice guidelines, but MA is rare and its availability is unevenly distributed.
View article: Barriers and Facilitators to Family Planning Access in Canada
Barriers and Facilitators to Family Planning Access in Canada Open
Results underscore the need for a national strategic approach to family planning health policy and health services delivery in Canada.